u/ahmed_okafor
Contributes reviews on supplier material. Based in Turku.
member · joined 13 Apr 2025
Comments — page 3 of 5
comment on [Discussion] we are measuring tier 3 at the wrong time and calling it noise in c/glp1uk · 13 points · 8 months ago
no naming online pharmacies that prescribe without a consultation
comment on [Question] discontinuation — what am I missing here in c/tapering · 2 points · 8 months ago
That is net peptide content, not purity. Different number, different meaning.
comment on weekly dosing is the most under-discussed thing in c/labresults in c/semaglutide · 39 points · 8 months ago
pens are overpriced, research vials are research grade, same molecule different price
comment on anyone else notice tendon kicking in around week 54 in c/bpc157 · 178 points · 8 months ago
Maintenance for 21 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.
comment on [PSA] write the concentration on the vial. that is the whole post. in c/semaglutide · 44 points · 8 months ago
the 2.4mg dose is not the target, it is just what the pen goes up to
comment on [Question] Ireland — has anyone got a straight answer on 503A in c/compounding · 6 points · 8 months ago
Sceptical. If this were true we would see it reflected in the data and we do not.
comment on [PSA] write the concentration on the vial. that is the whole post. in c/semaglutide · 63 points · 8 months ago
Small correction: the trial was 3 weeks, not 6. Does not change your point but people will quote it.
comment on switched from 1.7mg to 1.0mg and the nausea got better, not worse in c/intlshipping · 19 points · 9 months ago
This is correct. Variance is the story.
comment on someone explain small molecule to me like I have not read a paper in years in c/orforglipron · 48 points · 9 months ago
Which country? Half the answers in this thread only apply in Sweden.
comment on unpopular opinion: pricing is massively overrated in c/glp1uk · 118 points · 9 months ago
Yeah, the NHS waitlist is genuinely two years in most places.
comment on am I the only one who found rodent data harder than the injections in c/bpc157 · 68 points · 9 months ago
Yeah, rodent data does not scale to humans.
comment on am I the only one who found regulatory harder than the injections in c/bpc157 · 62 points · 11 months ago
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.
comment on telehealth is the most under-discussed thing in c/progresspics in c/compounding · 28 points · 11 months ago
no pharmacy referral codes, naming is fine, recruiting is not
comment on [Discussion] we are measuring Wegovy at the wrong time and calling it noise in c/semaglutide · 39 points · 12 months ago
the 2.4mg dose is not the target, it is just what the pen goes up to
comment on pricing: the version I wish someone had shown me in week 1 in c/glp1uk · 145 points · 1 year ago
say which nation, England, Scotland, Wales, NI differ
comment on week 11 check-in — 21kg down, injection-site soreness manageable, one thing confusing me in c/bpc157 · 12 points · 1 year ago
pentadecapeptide is BPC-157, the supply chain naming is a mess
comment on [Results] 32 weeks, 45kg, and regain was the hard part in c/tapering · 35 points · 1 year ago
say how long you were on and at what dose before taper
Yes, exactly this, and it is the bit that took me 31 weeks to accept.
comment on week 91 check-in — 6kg down, constipation manageable, one thing confusing me in c/compounding · 28 points · 1 year ago
Moved states and the compounding landscape changed completely. Different rules, different pharmacies, different costs.
comment on UK — 3 things I got wrong before I got it right in c/glp1uk · 1 points · 1 year ago
Boots stock is hit-and-miss by location
comment on [Meta] the state board rule is doing its job and people should stop complaining in c/compounding · 36 points · 1 year ago
telehealth costs state board plus compounding markup, total varies
Adding to this: 503B is doing more work than the comment implies.